NIVESTYM

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 916da2eeef9512b0
Drug Approval Canada Name: NIVESTYM
Product Name: NIVESTYM
Status: Marketed
Status Date: 2020-06-10
Original Market Date: 2020-06-10
Din: 02485656
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous , Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 20:16.00
Atc Original: L03AA02 FILGRASTIM
Atc Name: l 03 aa 02
Aig Number: 0123525001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

FILGRASTIM

480 MCG / 1.6 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

916da2eeef9512b0

Type

Standard